Gennex Laboratories Limited (BOM:531739)
12.00
+1.18 (10.91%)
At close: Aug 17, 2026
Gennex Laboratories Revenue
Gennex Laboratories had revenue of 418.50M INR in the quarter ending June 30, 2026, with 22.45% growth. This brings the company's revenue in the last twelve months to 1.78B, up 23.91% year-over-year. In the fiscal year ending March 31, 2026, Gennex Laboratories had annual revenue of 1.73B with 25.26% growth.
Revenue (ttm)
1.78B
Revenue Growth
+23.91%
P/S Ratio
1.48
Revenue / Employee
15.49M
Employees
115
Market Cap
2.63B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.73B | 348.38M | 25.26% |
| Mar 31, 2025 | 1.38B | 511.89M | 59.03% |
| Mar 31, 2024 | 867.14M | 211.11M | 32.18% |
| Mar 31, 2023 | 656.03M | 43.89M | 7.17% |
| Mar 31, 2022 | 612.14M | 15.65M | 2.62% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Medicamen Biotech | 2.06B |
| Ambalal Sarabhai Enterprises | 1.99B |
| Everest Organics | 1.92B |
| Astonea Labs | 1.48B |
| Trident Lifeline | 1.39B |
| Oxygenta Pharmaceutical | 1.35B |
| Kerala Ayurveda | 1.27B |
| BDH Industries | 996.09M |